Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Cash from Financing Activities (2016 - 2026)

Standard Biotools has reported Cash from Financing Activities over the past 16 years, most recently at $620000.0 for Q4 2025.

  • Quarterly Cash from Financing Activities rose 101.14% to $620000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $570000.0 through Dec 2025, up 100.56% year-over-year, with the annual reading at $570000.0 for FY2025, 100.56% up from the prior year.
  • Cash from Financing Activities was $620000.0 for Q4 2025 at Standard Biotools, up from -$112000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $213.0 million in Q2 2022 and troughed at -$54.5 million in Q4 2024.
  • The 5-year median for Cash from Financing Activities is -$270000.0 (2022), against an average of $6.8 million.
  • Year-over-year, Cash from Financing Activities surged 18474.29% in 2022 and then plummeted 23180.0% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $8.7 million in 2021, then crashed by 103.12% to -$270000.0 in 2022, then crashed by 271.48% to -$1.0 million in 2023, then plummeted by 5335.69% to -$54.5 million in 2024, then skyrocketed by 101.14% to $620000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Cash from Financing Activities are $620000.0 (Q4 2025), -$112000.0 (Q3 2025), and $108000.0 (Q2 2025).